UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 64

Sortiert nach

C-Type Lectin-Like Receptors As Emerging Orchestrators of Sterile Inflammation Represent Potential Therapeutic Targets

Frontiers in immunology, 2018-02, Vol.9, p.227-227

Chiffoleau, Elise

2018

Volltextzugriff (PDF)

C-Type Lectin-Like Receptors: Head or Tail in Cell Death Immunity

Frontiers in immunology, 2020-02, Vol.11, p.251-251

2020

Volltextzugriff (PDF)

Fibrinogen-like protein 2/fibroleukin induces long-term allograft survival in a rat model through regulatory B cells

PloS one, 2015-03, Vol.10 (3), p.e0119686

2015

Volltextzugriff (PDF)

Tmem176B and Tmem176A are associated with the immature state of dendritic cells

Journal of leukocyte biology, 2010-09, Vol.88 (3), p.507-515

2010

Volltextzugriff (PDF)

493 Identification of different classes of antagonist monoclonal antibodies targeting the myeloid checkpoint CLEC-1 and their associated anti-tumoral in vivo efficacies in humanized preclinical models

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A555-A555

2023

Volltextzugriff (PDF)

TRAF6 Is a Critical Factor for Dendritic Cell Maturation and Development

Immunity (Cambridge, Mass.), 2003-09, Vol.19 (3), p.353-363

2003

Volltextzugriff (PDF)

TLR9 ligand enhances proliferation of rat CD4+ T cell and modulates suppressive activity mediated by CD4+ CD25+ T cell

International immunology, 2007-02, Vol.19 (2), p.193-201

2007

Volltextzugriff (PDF)

212 CLEC-1 is a novel myeloid immune checkpoint for cancer immunotherapy limiting tumor cells phagocytosis and synergizing with tumor-targeted antibodies

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A231-A231

2020

Volltextzugriff (PDF)

Cell-surface C-type lectin-like receptor CLEC-1 dampens dendritic cell activation and downstream Th17 responses

Blood advances, 2017-03, Vol.1 (9), p.557-568

2017

Volltextzugriff (PDF)

LIMLE, a new molecule over-expressed following activation, is involved in the stimulatory properties of dendritic cells

PloS one, 2014-04, Vol.9 (4), p.e93894-e93894

2014

Volltextzugriff (PDF)

Characterization of Schlafen-3 expression in effector and regulatory T cells

Journal of leukocyte biology, 2010-03, Vol.87 (3), p.451-456

2010

Volltextzugriff (PDF)

CLEC-1 Restrains Acute Inflammatory Response and Recruitment of Neutrophils following Tissue Injury

The Journal of immunology (1950), 2024-04, Vol.212 (7), p.1178

2024

Volltextzugriff (PDF)

TNF Receptor-Associated Factor 6 Deficiency during Hemopoiesis Induces Th2-Polarized Inflammatory Disease

The Journal of immunology (1950), 2003-12, Vol.171 (11), p.5751-5759

2003

Volltextzugriff (PDF)

Tolerant Kidney Transplant Patients Produce B Cells with Regulatory Properties

Journal of the American Society of Nephrology, 2015-10, Vol.26 (10), p.2588-2598

2015

Volltextzugriff (PDF)

Human Tolerogenic Dendritic Cells Regulate Immune Responses through Lactate Synthesis

Cell metabolism, 2019-12, Vol.30 (6), p.1075-1090.e8

2019

Volltextzugriff (PDF)

Abstract 3423: CLEC-1 suppress dendritic cell antigen presentation and is a novel myeloid immune checkpoint target for cancer immunotherapy

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3423-3423

2020

Volltextzugriff (PDF)

Abstract 1636: CLEC-1 is a novel myeloid immune checkpoint for cancer immunotherapy limiting tumor cells phagocytosis and tumor antigen cross-presentation

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1636-1636

2021

Volltextzugriff (PDF)

Long‐Term Allograft Tolerance Is Characterized by the Accumulation of B Cells Exhibiting an Inhibited Profile

American journal of transplantation, 2011-03, Vol.11 (3), p.429-438

2011

Volltextzugriff (PDF)

Abstract 3259: CLEC-1 is a novel myeloid immune checkpoint for cancer immunotherapy controlling damaged and tumor cells phagocytosis

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3259-3259

2020

Volltextzugriff (PDF)

Dendritic Cells Require TMEM176A/B Ion Channels for Optimal MHC Class II Antigen Presentation to Naive CD4+ T Cells

The Journal of immunology (1950), 2021-07, Vol.207 (2), p.421-435

2021

Volltextzugriff (PDF)

B cells with regulatory properties in transplantation tolerance

World journal of transplantation, 2015-12, Vol.5 (4), p.196-208

2015

Volltextzugriff (PDF)

Regulatory B Cells with a Partial Defect in CD40 Signaling and Overexpressing Granzyme B Transfer Allograft Tolerance in Rodents

The Journal of immunology (1950), 2015-11, Vol.195 (10), p.5035-5044

2015

Volltextzugriff (PDF)

TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis

Nature medicine, 2006-09, Vol.12 (9), p.1088-1092

2006

Volltextzugriff (PDF)

Abstract 6365: TRIM21 is a novel endogenous partner of the inhibitory myeloid checkpoint CLEC-1 involved in tumor antigen cross-presentation

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.6365-6365

2023

Volltextzugriff (PDF)

RORγt+ cells selectively express redundant cation channels linked to the Golgi apparatus

Scientific reports, 2016-03, Vol.6 (1), p.23682-23682, Article 23682

2016

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(63)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Animals
(32)
Life Sciences & Biomedicine
(30)
Immunology
(21)
Rats
(19)
Life Sciences
(15)
Male
(13)
Mice
(13)
Rats, Inbred Lew
(13)
Humans
(11)
Heart Transplantation - Immunology
(9)
Transplantation
(9)
Biological And Medical Sciences
(8)
Medical Sciences
(7)
Surgery
(7)
Graft Rejection - Immunology
(6)
Human Health And Pathology
(6)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(6)
Cell Biology
(5)
Dendritic Cells
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

C-Type Lectin-Like Receptors As Emerging Orchestrators of Sterile Inflammation Represent Potential Therapeutic Targets

C-Type Lectin-Like Receptors: Head or Tail in Cell Death Immunity

Fibrinogen-like protein 2/fibroleukin induces long-term allograft survival in a rat model through regulatory B cells

Tmem176B and Tmem176A are associated with the immature state of dendritic cells

493 Identification of different classes of antagonist monoclonal antibodies targeting the myeloid checkpoint CLEC-1 and their associated anti-tumoral in vivo efficacies in humanized preclinical models

TRAF6 Is a Critical Factor for Dendritic Cell Maturation and Development

TLR9 ligand enhances proliferation of rat CD4+ T cell and modulates suppressive activity mediated by CD4+ CD25+ T cell

212 CLEC-1 is a novel myeloid immune checkpoint for cancer immunotherapy limiting tumor cells phagocytosis and synergizing with tumor-targeted antibodies

Cell-surface C-type lectin-like receptor CLEC-1 dampens dendritic cell activation and downstream Th17 responses

LIMLE, a new molecule over-expressed following activation, is involved in the stimulatory properties of dendritic cells

Characterization of Schlafen-3 expression in effector and regulatory T cells

CLEC-1 Restrains Acute Inflammatory Response and Recruitment of Neutrophils following Tissue Injury

TNF Receptor-Associated Factor 6 Deficiency during Hemopoiesis Induces Th2-Polarized Inflammatory Disease

Tolerant Kidney Transplant Patients Produce B Cells with Regulatory Properties

Human Tolerogenic Dendritic Cells Regulate Immune Responses through Lactate Synthesis

Abstract 3423: CLEC-1 suppress dendritic cell antigen presentation and is a novel myeloid immune checkpoint target for cancer immunotherapy

Abstract 1636: CLEC-1 is a novel myeloid immune checkpoint for cancer immunotherapy limiting tumor cells phagocytosis and tumor antigen cross-presentation

Long‐Term Allograft Tolerance Is Characterized by the Accumulation of B Cells Exhibiting an Inhibited Profile

Abstract 3259: CLEC-1 is a novel myeloid immune checkpoint for cancer immunotherapy controlling damaged and tumor cells phagocytosis

Dendritic Cells Require TMEM176A/B Ion Channels for Optimal MHC Class II Antigen Presentation to Naive CD4+ T Cells

B cells with regulatory properties in transplantation tolerance

Regulatory B Cells with a Partial Defect in CD40 Signaling and Overexpressing Granzyme B Transfer Allograft Tolerance in Rodents

TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis

Abstract 6365: TRIM21 is a novel endogenous partner of the inhibitory myeloid checkpoint CLEC-1 involved in tumor antigen cross-presentation

RORγt+ cells selectively express redundant cation channels linked to the Golgi apparatus

Suchergebnisse filtern